1![Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MATelNews Release Contact: Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MATelNews Release Contact:](https://www.pdfsearch.io/img/8486c9173b92cd76e749fb6d75908049.jpg) | Add to Reading ListSource URL: www.sunovion.comLanguage: English - Date: 2016-08-08 07:24:25
|
---|
2![spiral_会社案内_1406_Jpn spiral_会社案内_1406_Jpn](https://www.pdfsearch.io/img/b3e27147a817877f0fa8541054df9860.jpg) | Add to Reading ListSource URL: www.ds-pharma.co.jpLanguage: English - Date: 2016-07-25 21:11:28
|
---|
3![Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MATelNews Release Contact: Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MATelNews Release Contact:](https://www.pdfsearch.io/img/727a8dfd8920b0a6e2893ac928328358.jpg) | Add to Reading ListSource URL: www.sunovion.comLanguage: English - Date: 2016-07-22 08:01:54
|
---|
4![Research & Development Sumitomo Dainippon Pharma is actively investing its resources in new areas such as disease fields where no approved drugs exist and Regenerative Medicine & Cell Therapy as well as the focus therap Research & Development Sumitomo Dainippon Pharma is actively investing its resources in new areas such as disease fields where no approved drugs exist and Regenerative Medicine & Cell Therapy as well as the focus therap](https://www.pdfsearch.io/img/afda596f988c52f39a042f559245cc1a.jpg) | Add to Reading ListSource URL: www.ds-pharma.comLanguage: English - Date: 2015-09-03 20:48:20
|
---|
5![CSR Management Basic Position on CSR Declaration of Conduct Sumitomo Dainippon Pharma sets forth its commitment to serve society in the Company’s Corporate Mission, and the aim CSR Management Basic Position on CSR Declaration of Conduct Sumitomo Dainippon Pharma sets forth its commitment to serve society in the Company’s Corporate Mission, and the aim](https://www.pdfsearch.io/img/17060c1d172103a53cc4a15d7e20baeb.jpg) | Add to Reading ListSource URL: www.ds-pharma.comLanguage: English - Date: 2015-09-07 12:29:43
|
---|
6![Financial Highlights Material Inputs and Outcomes The Sumitomo Dainippon Pharma Group has been promoting the third Mid-Term Business Plan, which has Sustained Growth in the Quest for Further Innovation as its slogan. Th Financial Highlights Material Inputs and Outcomes The Sumitomo Dainippon Pharma Group has been promoting the third Mid-Term Business Plan, which has Sustained Growth in the Quest for Further Innovation as its slogan. Th](https://www.pdfsearch.io/img/4ddf76faf9afd906c7b06c20d2138b95.jpg) | Add to Reading ListSource URL: www.ds-pharma.comLanguage: English - Date: 2015-09-03 20:45:32
|
---|
7![Corporate Governance Basic Approach to Corporate Governance Reasons for Appointment of Outside Directors Sumitomo Dainippon Pharma strengthens the internal control system, including risk management, to ensure business Corporate Governance Basic Approach to Corporate Governance Reasons for Appointment of Outside Directors Sumitomo Dainippon Pharma strengthens the internal control system, including risk management, to ensure business](https://www.pdfsearch.io/img/85f4623aac1198e330a3f8787926c945.jpg) | Add to Reading ListSource URL: www.ds-pharma.comLanguage: English - Date: 2015-09-03 20:50:22
|
---|
8![March 3, 2015 Toray Industries, Inc. Japan Tobacco Inc. Torii Pharmaceutical Co., Ltd. Sumitomo Dainippon Pharma Co., Ltd. March 3, 2015 Toray Industries, Inc. Japan Tobacco Inc. Torii Pharmaceutical Co., Ltd. Sumitomo Dainippon Pharma Co., Ltd.](https://www.pdfsearch.io/img/9d9276d447b7fd0a61b25cc22099ea73.jpg) | Add to Reading ListSource URL: www.jt.comLanguage: English - Date: 2015-03-02 22:33:16
|
---|
9![Contents Overview Mission Contents Overview Mission](https://www.pdfsearch.io/img/25abe693bcbb1390344e03c10b058e9a.jpg) | Add to Reading ListSource URL: www.ds-pharma.comLanguage: English - Date: 2014-10-23 23:41:00
|
---|
10![Special Feature Innovation New Opportunities in Regenerative Medicine & Cell Therapy In its third Mid-term Business Plan (the 3rd MTBP), Sumitomo Dainippon Pharma points to Special Feature Innovation New Opportunities in Regenerative Medicine & Cell Therapy In its third Mid-term Business Plan (the 3rd MTBP), Sumitomo Dainippon Pharma points to](https://www.pdfsearch.io/img/403b219443976619b3ed819484fea7ba.jpg) | Add to Reading ListSource URL: www.ds-pharma.comLanguage: English - Date: 2014-11-05 02:10:52
|
---|